Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine ...

We can't stand by while Washington plays politics with our health, our future, and our hardest-working families.

U.S. awards Moderna $590 million to speed up ... will allow us to stay ahead and ensure that Americans have the tools they need to stay safe," outgoing HHS Secretary Xavier Becerra said in ...

The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...

Since 2023, Moderna has been working to create a “pandemic influenza vaccine” which would help protect against certain viruses, including the H5N1 bird flu. The new funds build on the $176 ...

Moderna is set to receive $176 million in federal ... learned during the COVID-19 pandemic and used them to better prepare for future public health crises,” HHS Secretary Xavier Becerra said ...

Becerra says he’s mulling options now that his time in the Biden Cabinet is over. Some allies say he’s strongly considering a run for California governor. The main challenge he faced leading ...

Today’s edition: Moderna’s CEO heads to Capitol Hill. ... Health and Human Services Secretary Xavier Becerra’s budget blitz is beginning.

This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research. Moderna’s vaccine is designed to target H5 and ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...